thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » Omicron 4 Times Virulent than Delta Variant – New Japanese Study

COVID-19

Omicron 4 Times Virulent than Delta Variant – New Japanese Study

TheNewsFacts
Last updated: December 9, 2021 1:58 pm
TheNewsFacts
Share
Omicron Far Powerful Than Delta - Japanese Study
SHARE

When a Japanese scientist analyzed genome data from South Africans, they established that the Omicron variant of Covid-19 is over 4 times more transmissible in its early stage than delta.

The study by a Japanese scientist, a health ministry advisor in Japan suggests the is finding likely to confirm fears about the new strain’s contagiousness.

“The omicron variant transmits more, and escapes immunity built naturally and through vaccines more,” Nishiura wrote in his findings, which were presented at a meeting of the health ministry’s advisory panel on Wednesday.

Nishiura’s study hasn’t been peer-reviewed and published in a scientific journal. The new analysis was conducted using the same method he used in a July study published by the Eurosurveillance medical journal on delta’s predicted dominance ahead of the Tokyo Olympics.

Omicron ‘transmits more and escapes immunity’: New study in Japan claims

Omicron
Omicron has 4 times more transmission strength over Delta Variant

Hiroshi Nishiura, a professor of health and environmental sciences at Kyoto University who specializes in mathematical modeling of infectious diseases, analyzed genome data available through November 26 in South Africans in Gauteng province.

Concerns are swirling globally that omicron could deal the world a bigger blow than even delta, and the World Health Organization has cautioned that it could fuel surges with “severe consequences.”

The jump in COVID19 positive cases in South Africa in the wake of the variant’s emergence hasn’t yet overwhelmed hospitals, leading to some optimism that it may only cause mostly mild illness. Pfizer Inc. and BioNTech SE also said this week that a booster dose of their vaccine could fortify protection against the strain.

TAGGED: COVID 19, Delta Variant, Omicron, Omicron News, Omicron Threat, Omicron Vs Delta, Variants of Concern
Share This Article
Twitter Email Copy Link Print
Previous Article 4 Big Nations Lead Beijing Winter Olympics Boycott Beijing Olympics 2022 Boycott: Canada Joins the List of 3 Big Nations
Next Article Why Ranbir Kapoor took the Spotlight at RRR Trailer Launch? Why Ranbir Kapoor took the Spotlight at RRR Trailer Launch?

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

Reliance Covid-19 Vaccine Candidate Trial to Begin

Reliance Covid-19 vaccine candidate has got the regulator nod to conduct trials in India. Reliance…

By TheNewsFacts

Milan Vs Inter 2023: Inter Milan Wins 7th Italian Super Cup Convincingly

Milan vs Inter : Inter Milan emerged victorious over their arch-rivals AC Milan in the…

By TheNewsFacts

Brazil vs South Korea: Neymar dribbles his magic in Brazil’s 4-1 win

Brazil vs South Korea was a spectacular knockout match to watch and the Brazilian team…

By TheNewsFacts

You Might Also Like

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By NewsFacts Bureau
Covid-19 JN.!
COVID-19Health

JN.1, A New Subvariant of COVID-19 in Kerala: Health Ministry Vigilant

By SK Panicker
India's Covid-19 Cases Continue to Decline with 9,355 New Infections
COVID-19

India’s Covid-19 Cases Continue to Decline with 9,355 New Infections

By TheNewsFacts
COVAXIN
COVID Vaccines

COVAXIN production to be demand-driven, says Bharat Biotech

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?